4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-058467
Chief Financial Officer gave up 683 shares (to pay taxes)
- Chief Financial Officer acquired 1,752 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-11-18 | Option exercise | +1,752 | 87,315 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2022-11-18 | Shares withheld for taxes | −683 | $14.75 | $10,074 | 86,632 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2022-11-18 | Option exercise · Restricted Stock Units | −1,752 | 22,202 | D | ||
Loading xslF345X03/doc4.xml…